Diabetes Prevention Program: Difference between revisions

no edit summary
(Created page with "{{Program |ProgramName=Diabetes Prevention Program |ProgramType=Initiative |OrgSponsor=National Institute of Diabetes and Digestive and Kidney Diseases |TopOrganization=Department of Health and Human Services |CreationLegislation=Public Law 103-183 |Purpose=The Diabetes Prevention Program was designed to determine whether lifestyle changes or medication could prevent or delay the onset of type 2 diabetes in individuals with impaired glucose tolerance. It aimed to provide...")
 
No edit summary
 
Line 5: Line 5:
|TopOrganization=Department of Health and Human Services
|TopOrganization=Department of Health and Human Services
|CreationLegislation=Public Law 103-183
|CreationLegislation=Public Law 103-183
|Purpose=The Diabetes Prevention Program was designed to determine whether lifestyle changes or medication could prevent or delay the onset of type 2 diabetes in individuals with impaired glucose tolerance. It aimed to provide definitive evidence to guide clinical and public health strategies for diabetes prevention.
|Purpose=Diabetes Prevention Program tested if lifestyle changes or meds could delay type 2 diabetes, aiming to guide health strategies with solid evidence.
|Website=https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/diabetes-prevention-program-dpp
|Website=https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/diabetes-prevention-program-dpp
|ProgramStart=1996
|ProgramStart=1996
|InitialFunding=$174.3 million
|InitialFunding=$174.3 million
|Duration=1996–2002
|Duration=1996–2002
|Historic=true
|Historic=Yes
}}
}}
The '''Diabetes Prevention Program''' (DPP) was a landmark multicenter clinical research study initiated by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the Department of Health and Human Services to address the rising incidence of type 2 diabetes. Conducted from 1996 to 2002, the DPP demonstrated that intensive lifestyle interventions—focused on diet, exercise, and weight loss—could reduce the risk of developing type 2 diabetes by 58% in high-risk individuals, while metformin, a common diabetes medication, reduced the risk by 31%. This initiative, involving over 3,000 participants across 27 U.S. sites, provided foundational evidence for diabetes prevention strategies and has since transitioned into the ongoing Diabetes Prevention Program Outcomes Study (DPPOS) to assess long-term impacts.
The '''Diabetes Prevention Program''' (DPP) was a landmark multicenter clinical research study initiated by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) within the Department of Health and Human Services to address the rising incidence of type 2 diabetes. Conducted from 1996 to 2002, the DPP demonstrated that intensive lifestyle interventions—focused on diet, exercise, and weight loss—could reduce the risk of developing type 2 diabetes by 58% in high-risk individuals, while metformin, a common diabetes medication, reduced the risk by 31%. This initiative, involving over 3,000 participants across 27 U.S. sites, provided foundational evidence for diabetes prevention strategies and has since transitioned into the ongoing Diabetes Prevention Program Outcomes Study (DPPOS) to assess long-term impacts.